Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18968658 | PROCESS FOR REDUCING BY-PRODUCTS IN BISPHENOL A REACTION SYSTEM | December 2024 | May 2025 | Allow | 6 | 0 | 0 | No | No |
| 18924505 | BISPHENOL A PREPARATION PROCESS AND DEVICE THEREOF | October 2024 | April 2025 | Allow | 5 | 0 | 0 | No | No |
| 18856957 | SYNTHESIS AND PURIFICATION OF CBDA | October 2024 | February 2025 | Allow | 4 | 0 | 0 | No | No |
| 18794655 | PROCESS FOR DEBROMINATION OF NOVEL BROMINATED FLAME RETARDANTS USING Zn-BASED ADDITIVES | August 2024 | December 2024 | Allow | 4 | 0 | 0 | No | No |
| 18654660 | LIPID FORMULATIONS FOR GENE EDITING | May 2024 | January 2025 | Allow | 9 | 1 | 0 | No | No |
| 18614086 | SUBSTITUTED BENZODIAZOLES AND USE THEREOF IN THERAPY | March 2024 | January 2025 | Allow | 10 | 1 | 0 | No | No |
| 18602836 | Methods Of Treating Multiple Sclerosis | March 2024 | March 2025 | Allow | 12 | 1 | 0 | No | No |
| 18416953 | METHODS OF TREATMENT WITH COMBINATIONS OF CANNABIDIOL AND PSILOCYBIN | January 2024 | April 2025 | Allow | 15 | 2 | 0 | No | No |
| 18416577 | RXR AGONIST SALT FORM, POLYMORPHS THEREOF, AND USES THEREOF | January 2024 | February 2025 | Allow | 13 | 1 | 0 | No | No |
| 18510437 | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | November 2023 | February 2025 | Allow | 15 | 1 | 0 | No | No |
| 18388698 | HYDROXY GAS GENERATOR | November 2023 | March 2025 | Allow | 16 | 1 | 0 | No | No |
| 18489642 | COMBINATION THERAPY USING RILUZOLE TO ENHANCE TUMOR SENSITIVITY TO IONIZING RADIATION | October 2023 | February 2025 | Allow | 16 | 1 | 0 | No | No |
| 18488342 | PRODRUGS OF TREPROSTINIL | October 2023 | March 2025 | Allow | 17 | 2 | 0 | No | No |
| 18381035 | METHODS FOR REMOVING PESTICDES FROM CANNABIS PRODUCTS | October 2023 | March 2025 | Abandon | 17 | 1 | 0 | No | No |
| 18479002 | METHOD FOR PREPARING PICKERING MINIEMULSION AND ITS CATALYTIC APPLICATION | September 2023 | September 2024 | Allow | 11 | 0 | 0 | No | No |
| 18458741 | METHOD AND SYSTEM FOR EXTRACTION OF MINERALS BASED ON DIVALENT CATIONS FROM BRINE | August 2023 | January 2025 | Allow | 17 | 1 | 0 | No | No |
| 18239013 | SYSTEMS, APPARATUS AND METHODS FOR SEPARATING ACTINIUM, RADIUM, AND THORIUM | August 2023 | May 2025 | Allow | 20 | 2 | 0 | No | No |
| 18352623 | PROCESS FOR PURIFICATION OF PRODUCTS | July 2023 | February 2025 | Allow | 19 | 1 | 0 | No | No |
| 18349693 | SOLID PEROXYALPHAHYDROXYCARBOXYLIC ACID GENERATION COMPOSITIONS AND THE USE THEREOF | July 2023 | November 2024 | Allow | 16 | 1 | 0 | No | No |
| 18213947 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | June 2023 | March 2025 | Allow | 20 | 1 | 0 | No | No |
| 18335877 | PSYCHOTROPIC AGENTS AND USES THEREOF | June 2023 | February 2025 | Abandon | 20 | 1 | 0 | No | No |
| 18334815 | METHOD FOR MAKING ALDEHYDES, ALCOHOLS, AMIDES, AND CARBOXYLIC ACIDS FROM PLASTIC PYROLYSIS OIL | June 2023 | February 2025 | Allow | 20 | 2 | 0 | No | No |
| 18198899 | DIRECT CATALYTIC CONVERSION OF ALCOHOLS TO OLEFINS OF HIGHER CARBON NUMBER WITH REDUCED ETHYLENE PRODUCTION | May 2023 | November 2024 | Allow | 18 | 2 | 0 | No | No |
| 18198809 | Branched Aldehyde Production | May 2023 | February 2025 | Allow | 21 | 2 | 0 | No | No |
| 18316471 | HETEROCYCLIC COMPOUNDS, PREPARATION METHODS THEREFOR, AND METHODS OF USES THEREOF | May 2023 | August 2024 | Allow | 15 | 0 | 0 | No | No |
| 18133846 | SYSTEM AND METHOD FOR TREATMENT OF PLANTS FOR SYNTHESIS OF COMPOUNDS THEREFROM | April 2023 | August 2024 | Allow | 16 | 1 | 0 | No | No |
| 18177450 | PROCESS OF PREPARING 3-FLUORO-5(((1R,2AR)-3,3,4,4-TETRAFLUORO-1,2A-DIHYDROXY-2,2A,3,4-TETRAHYDRO-1H-CYCLOPENTA[CD]INDEN-7-YL)-OXY)BENZONITRILE | March 2023 | February 2025 | Allow | 24 | 1 | 0 | No | No |
| 18111822 | Synthetic Cannabinoid Compounds for Treatment of Pain and Anxiety | February 2023 | June 2024 | Allow | 16 | 0 | 0 | No | No |
| 18170858 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS | February 2023 | July 2024 | Allow | 17 | 0 | 0 | No | No |
| 18164309 | PROCESS FOR PREPARING TAPINAROF | February 2023 | December 2024 | Allow | 22 | 1 | 0 | No | No |
| 18164136 | BRANCHED TAIL LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | February 2023 | January 2025 | Allow | 23 | 1 | 0 | No | No |
| 18102761 | CRYSTALLINE FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE | January 2023 | September 2024 | Allow | 20 | 1 | 0 | No | No |
| 18094663 | Systems for Removal of Detergents from Aqueous Solutions | January 2023 | September 2024 | Allow | 20 | 1 | 0 | No | No |
| 18079984 | METHODS FOR ISOLATING COMPOUNDS | December 2022 | December 2024 | Allow | 24 | 2 | 0 | No | No |
| 18076902 | FLUID CATALYTIC CRACKING OF P-CRESOL DIMER INTO PHENOLIC MONOMERS AND PROCESS THEREOF | December 2022 | January 2025 | Allow | 25 | 0 | 0 | No | No |
| 17999978 | Organic Catalyst for Non-Aqueous Aldol Condensation | November 2022 | April 2025 | Allow | 29 | 1 | 0 | No | No |
| 17990777 | Topical Medicament for Use in Treatment of Anorectal Inflammation | November 2022 | December 2024 | Allow | 24 | 2 | 0 | No | No |
| 17990991 | POST EXTRACTION PURIFICATION OF TERPENES | November 2022 | January 2025 | Allow | 26 | 0 | 0 | No | No |
| 18057394 | METHOD FOR CONTINUOUS SYNTHESIS OF ACYLNAPHTHALENE WITH ACYLATION LIQUID | November 2022 | March 2025 | Allow | 38 | 0 | 0 | No | No |
| 17999273 | METHODS OF ARENE ALKENYLATION | November 2022 | April 2025 | Allow | 29 | 1 | 0 | No | No |
| 17923284 | POLYMORPHIC FORMS OF (R)-OXYBUTYNIN HYDROCHLORIDE | November 2022 | July 2025 | Allow | 32 | 2 | 0 | No | No |
| 17965145 | COMPOUNDS AND USES THEREOF | October 2022 | September 2024 | Allow | 23 | 1 | 0 | No | No |
| 17963549 | METHOD FOR PRODUCING (METH)ACRYLOXY GROUP-CONTAINING ORGANOSILICON COMPOUNDS | October 2022 | June 2025 | Allow | 32 | 0 | 1 | No | No |
| 17960092 | ORGANIC ANION LITHIUM IONIC COCRYSTAL COMPOUNDS AND COMPOSITIONS | October 2022 | December 2024 | Allow | 27 | 1 | 0 | No | No |
| 17954874 | ALKOXYLATED SECONDARY ALCOHOL | September 2022 | September 2024 | Allow | 23 | 1 | 0 | No | No |
| 17951560 | Treatment of Parasitic Infections of Fish Surfaces | September 2022 | May 2025 | Allow | 32 | 0 | 0 | No | No |
| 17906843 | Hydroformylation Catalysts Comprising Fluorophosphine Ligands and Precursors Thereof | September 2022 | April 2025 | Allow | 31 | 1 | 0 | No | No |
| 17946905 | COMPOSITIONS AND METHODS FOR TREATMENT OF PRE-CANCEROUS SKIN LESIONS | September 2022 | August 2024 | Allow | 23 | 1 | 0 | No | No |
| 17821967 | PRODUCTION OF GLYCOLALDEHYDE BY THERMOLYTIC FRAGMENTATION | August 2022 | October 2024 | Allow | 26 | 1 | 0 | No | No |
| 17800452 | Use of a Multidentate Phosphite Ligand in the Catalytic Synthesis of Adiponitrile | August 2022 | April 2025 | Allow | 32 | 0 | 0 | No | No |
| 17904208 | CALPAIN-2 INHIBITOR COMPOUNDS AND METHODS OF TREATMENT | August 2022 | April 2025 | Allow | 32 | 0 | 0 | No | No |
| 17798607 | LOW-PRESSURE HYDROFORMYLATION OF DIISOBUTENE | August 2022 | December 2024 | Allow | 28 | 0 | 0 | No | No |
| 17795723 | METHOD AND SYSTEM FOR OXIDIZING CUMENE AND HYDROCARBONS | July 2022 | March 2025 | Allow | 32 | 1 | 0 | No | No |
| 17759436 | A METHOD FOR DIRECT HYDROGENATION OF MALEIC ANHYDRIDE TO PRODUCE 1,4-BUTANEDIOL AND CO-PRODUCE SUCCINIC ANHYDRIDE | July 2022 | April 2025 | Allow | 33 | 0 | 0 | No | No |
| 17865037 | CURCUMINOIDS, ANALOGS THEREOF, AND METHODS OF MAKING THE SAME | July 2022 | January 2025 | Allow | 30 | 2 | 0 | No | No |
| 17808877 | CANNABIS PROCESSING SYSTEMS AND METHODS | June 2022 | December 2024 | Allow | 30 | 1 | 0 | No | No |
| 17847215 | PROCESS OF MAKING PSEUDOIONONE AND HYDROXY PSEUDOIONONE IN AQUEOUS MIXTURES COMPRISING CITRAL AND ACETONE, COMPRISING ADDING FIRST AND SECOND AMOUNTS OF HYDROXIDE | June 2022 | November 2024 | Abandon | 29 | 1 | 0 | No | No |
| 17788237 | DEHYDROGENATION PROCESS | June 2022 | November 2024 | Allow | 29 | 0 | 0 | No | No |
| 17785586 | PROCESS FOR THE PREPARATION OF BRIVARACETAM | June 2022 | April 2025 | Allow | 34 | 0 | 0 | No | No |
| 17784015 | PREPARATION METHOD FOR OPTICALLY ACTIVE CITRONELLAL | June 2022 | November 2024 | Allow | 29 | 0 | 0 | No | No |
| 17834382 | DIMETHYLCYCLOBUTANONE COMPOUNDS, DIMETHYLCYCLOBUTANE COMPOUNDS, AND PROCESSES FOR PREPARING THE SAME | June 2022 | August 2024 | Allow | 26 | 1 | 0 | No | No |
| 17834151 | PROCESS FOR THE PRODUCTION OF 1,4-BUTANEDIOL FROM RENEWABLE SOURCES AND POLYESTERS OBTAINED THEREFROM | June 2022 | August 2024 | Allow | 27 | 1 | 0 | No | No |
| 17775856 | METHODS TO SEPARATE CANNABINOIDS FROM IMPURITIES BY CRYSTALLIZATION | May 2022 | April 2025 | Allow | 35 | 0 | 0 | No | No |
| 17739507 | THERMOLYTIC FRAGMENTATION OF SUGARS USING RESISTANCE HEATING | May 2022 | October 2024 | Allow | 29 | 1 | 0 | No | No |
| 17773961 | PROCESS FOR CONVERTING METHANOL TO FORMALDEHYDE | May 2022 | September 2024 | Allow | 29 | 1 | 0 | No | No |
| 17773287 | INDIUM PRECURSOR COMPOUND, METHOD OF PREPARING THIN FILM USING THE SAME, AND BOARD PREPARED USING THE SAME | April 2022 | December 2024 | Allow | 32 | 1 | 1 | No | No |
| 17771721 | FLUORINE SUBSTITUTED CYCLOHEXENE ANALOGUES OF GAMMA- AMINOBUTYRIC ACID (GABA) | April 2022 | June 2025 | Allow | 38 | 1 | 0 | No | No |
| 17726860 | METHODS OF MODIFYING A NATURALLY OCCURRING CANNABIS RAW PLANT MATERIAL, A PURIFIED CANNABIS PRODUCT FROM A NATURALLY OCCURRING CANNABIS RAW PLANT MATERIAL, AND A MODIFIED CANNABIS PRODUCT FROM A NATURALLY OCCURRING CANNABIS RAW PLANT MATERIAL | April 2022 | April 2025 | Allow | 35 | 1 | 0 | No | No |
| 17725853 | SPIRO-BISPHOSPHOROUS COMPOUND, AND PREPARATION AND APPLICATION THEREOF | April 2022 | September 2024 | Allow | 29 | 0 | 0 | No | No |
| 17769151 | METHOD FOR PRODUCING 2,4-DIALKYLBENZALDEHYDE | April 2022 | August 2024 | Allow | 28 | 1 | 0 | No | No |
| 17769200 | CONTINUOUS POST-TREATMENT METHOD AND DEVICE FOR PENEM COMPOUND | April 2022 | March 2025 | Allow | 35 | 0 | 0 | No | No |
| 17764450 | ASTAXANTHIN ESTERS AND METHODS OF USE THEREOF | March 2022 | February 2025 | Allow | 35 | 0 | 0 | No | No |
| 17763718 | LIGHT INDUCED CATALYTIC C-H OXYGENATION OF ALKANES | March 2022 | November 2024 | Allow | 32 | 1 | 0 | No | No |
| 17700503 | 3,3,3',3'-TETRAMETHYL-1,1'-SPIROBIINDANE-7,7'-DIOL | March 2022 | January 2025 | Allow | 34 | 1 | 0 | No | No |
| 17684020 | COMPOSITIONS COMPRISING PHOSPHOINOSITIDE 3-KINASE INHIBITORS AND A SECOND ANTIPROLIFERATIVE AGENT | March 2022 | November 2024 | Allow | 33 | 1 | 0 | No | No |
| 17680560 | CONTINUOUS HYDROLYZATION APPARATUS AND CONTINUOUS HYDROLYZATION METHOD | February 2022 | January 2025 | Allow | 35 | 1 | 0 | No | No |
| 17635711 | 2,2,6-TRIMETHYL-4,5-DIHYDRO-3H-OXEPINE AS AROMA INGREDIENT | February 2022 | February 2025 | Allow | 36 | 0 | 0 | No | No |
| 17592449 | SUPERCRITICAL FLUID EXTRACTION PROCESS WITH INTEGRATED PRESSURE EXCHANGER | February 2022 | July 2024 | Allow | 30 | 0 | 0 | No | No |
| 17631583 | SEPARATION OF CANNABINOIDS FROM MIXTURES THEREOF BY EXTRACTION AND DISTILLATION | January 2022 | July 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17597822 | RECYCLE CONTENT (C4)ALKANAL | January 2022 | May 2025 | Allow | 40 | 2 | 0 | No | No |
| 17630130 | ISOLATION OF CHROMOPLASTID CAROTENOIDS FROM FRUITS | January 2022 | August 2024 | Allow | 30 | 0 | 0 | No | No |
| 17627153 | METHOD FOR THE TREATMENT OF A COMPOSITION COMPRISING NATURAL VANILLIN | January 2022 | September 2024 | Allow | 32 | 1 | 0 | No | No |
| 17622377 | WNT ACTIVATORS AND METHODS OF USE | December 2021 | May 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17559745 | METHOD AND APPARATUS FOR MANUFACTURING NITROGEN TETROXIDE | December 2021 | August 2024 | Allow | 32 | 1 | 0 | No | No |
| 17645189 | MULTIPLE CHARGED IONIC COMPOUNDS DERIVED FROM POLYAMINES AND COMPOSITIONS THEREOF AND METHODS OF PREPARATION THEREOF | December 2021 | September 2024 | Allow | 33 | 1 | 0 | No | No |
| 17556804 | CATALYST FOR DEHYDROGENATION OF LIGHT ALKANES | December 2021 | June 2024 | Allow | 30 | 1 | 0 | No | No |
| 17619329 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | December 2021 | July 2024 | Allow | 31 | 1 | 0 | No | No |
| 17644045 | 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS | December 2021 | April 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17548249 | PROCESS FOR REMOVING THC FROM CANNABINOIDS | December 2021 | May 2024 | Allow | 29 | 1 | 1 | No | No |
| 17541235 | Branched Products | December 2021 | August 2023 | Allow | 21 | 2 | 0 | No | No |
| 17610487 | METHODS AND MATERIALS FOR TREATING CANCER | November 2021 | May 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17519266 | DOSING AND EFFECT OF C5a ANTAGONIST WITH ANCA-ASSOCIATED VASCULITIS | November 2021 | March 2025 | Allow | 40 | 1 | 0 | No | No |
| 17606711 | METHOD FOR PREPARING ACRYLONITRILE DIMER | October 2021 | March 2025 | Allow | 41 | 1 | 0 | No | No |
| 17602909 | METHOD OF TREATING TUMOURS | October 2021 | October 2024 | Allow | 36 | 0 | 0 | No | No |
| 17593662 | FUNGICIDAL COMPOUNDS | September 2021 | July 2024 | Allow | 34 | 1 | 0 | No | No |
| 17440415 | D-METYROSINE COMPOSITIONS AND METHODS FOR PREPARING SAME | September 2021 | October 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17311020 | METHOD FOR PRODUCING 3,5-DIHYDROXY-4-METHOXYBENZYL ALCOHOL FROM BIVALVE | June 2021 | November 2024 | Allow | 42 | 3 | 0 | Yes | No |
| 17298692 | PROCESS FOR PRODUCING 1-(4-ISOBUTYLPHENYL)ETHANOL BY HYDROGENATION OF 1-(4-ISOBUTYL-PHENYL)ETHANONE IN THE PRESENCE OF A CATALYST COMPOSITION COMPRISING COPPER | June 2021 | March 2025 | Allow | 46 | 3 | 0 | No | No |
| 17290355 | ORGANOSULFUR COMPOUNDS | April 2021 | May 2024 | Abandon | 37 | 1 | 0 | No | No |
| 16845032 | CROTONYL ALCOHOL CASSIC ACID ESTER WITH ANTIBACTERIAL ACTIVITY AND A METHOD OF PREPARING THE SAME | April 2020 | May 2020 | Allow | 2 | 0 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WITHERSPOON, SIKARL A.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 66.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner WITHERSPOON, SIKARL A works in Art Unit 1692 and has examined 361 patent applications in our dataset. With an allowance rate of 97.5%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 18 months.
Examiner WITHERSPOON, SIKARL A's allowance rate of 97.5% places them in the 92% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.
On average, applications examined by WITHERSPOON, SIKARL A receive 0.84 office actions before reaching final disposition. This places the examiner in the 8% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by WITHERSPOON, SIKARL A is 18 months. This places the examiner in the 93% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.
Conducting an examiner interview provides a +2.5% benefit to allowance rate for applications examined by WITHERSPOON, SIKARL A. This interview benefit is in the 21% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 41.5% of applications are subsequently allowed. This success rate is in the 92% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 69.2% of cases where such amendments are filed. This entry rate is in the 89% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 86% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 43.3% are granted (fully or in part). This grant rate is in the 46% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 17.2% of allowed cases (in the 99% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.6% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.